CVE-2024-5930

VIPRE Advanced Security Incorrect Permission Assignment Local Privilege Escalation Vulnerability

Description

VIPRE Advanced Security Incorrect Permission Assignment Local Privilege Escalation Vulnerability. This vulnerability allows local attackers to escalate privileges on affected installations of VIPRE Advanced Security. An attacker must first obtain the ability to execute low-privileged code on the target system in order to exploit this vulnerability. The specific flaw exists within the Anti Malware Service. The issue results from incorrect permissions on a file. An attacker can leverage this vulnerability to escalate privileges and execute arbitrary code in the context of SYSTEM. Was ZDI-CAN-22345.

Category

7.8
CVSS
Severity: High
CVSS 3.1 •
CVSS 3.0 •
EPSS 0.03%
Vendor Advisory vipre.com
Affected: VIPRE Advanced Security
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2024-5930?
CVE-2024-5930 has been scored as a high severity vulnerability.
How to fix CVE-2024-5930?
To fix CVE-2024-5930, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2024-5930 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2024-5930 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2024-5930?
CVE-2024-5930 affects VIPRE Advanced Security.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.